<DOC>
	<DOCNO>NCT02148016</DOCNO>
	<brief_summary>Corneal disease lead cause blindness world . A shortage corneal donor tissue prevent many patient regain vision . Additionally , refractive error myopia major cause impair visual function worldwide . Although refractive error correctable procedure modify refractive power cornea , procedure often weaken corneal integrity risk complication . This study aim evaluate safety efficacy corneal surface epithelium repair regeneration treatment corneal surface disease refractive error use autologous limbal stem cell transplantation .</brief_summary>
	<brief_title>Corneal Epithelium Repair Therapy Using Autologous Limbal Stem Cell Transplantation</brief_title>
	<detailed_description>The corneal surface comprise unique type non-keratinized epithelial cell . These cell arrange orderly fashion , essential vision maintain transparency visual axis . Chemical injury pterygium may damage limbus , zone cornea bulbar conjunctiva , cause limbal stem cell ( LSC ) deficiency . They represent major treatable cause vision loss worldwide . A shortage corneal donor tissue prevents many patient regain vision , necessitate new treatment strategy circumvent limitation . Transplantation stem cell represent appeal therapeutic strategy regenerative medicine , use endogenous stem cell provide possible solution problem immune rejection . Currently , LASIK ( laser-assisted situ keratomileusis ) commonly perform laser vision correction procedure world ( 10 million surgery year ) ; however , major disadvantage weaken corneal integrity structure predispose complication keratectasia keratoconus ( bulge cornea ) vision loss . An alternative photo-refractive keratectomy ( PRK ) , remove corneal epithelium anterior stroma minimize incidence keratectasia keratoconus . The primary drawback PRK require long recovery time ( corneal epithelium must regenerate patient 's LSCs ) may result blurry vision pain due corneal pain nerve fiber exposure removal epithelium . Coverage expose corneal stroma tissue immediately surgery LSC-derived corneal epithelial cell solve key bottleneck make laser eye surgery safer comfortable million people . It known corneal renewal repair mediate stem cell limbus . Autologous LSC transplantation report previously ( Rama et al. ) . However , mouse feeder cell require expand LSCs culture . We successfully develop feeder-free , chemically define medium expand LSCs . These expand LSCs repair regenerate corneal surface ( Ouyang et al. , press ) . Hypothesis : The trial demonstrate whether new technique , transplantation LSCs expand limbal tissue uninjured eye , improve visual function patient unilateral corneal ocular surface disease . In addition , show whether rapid recovery improve visual outcome follow PRK expand LSCs use cover cornea . The study also compare incidence complication characterize visual outcome patient treat new technique versus control technique .</detailed_description>
	<mesh_term>Myopia</mesh_term>
	<mesh_term>Pterygium</mesh_term>
	<mesh_term>Hyperopia</mesh_term>
	<mesh_term>Corneal Diseases</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Monocular corneal chemical injury pterygium , refractive error great +/ 2D Informed consent sign patient legal guardian Patients history corneal perforation surgery Patients eye diseases Patients history severe cardiovascular , liver , kidney , endocrine , hematopoietic disease , diabetes , immune deficiency disorder Pregnant lactate woman Patients participate clinical trial Patients history mental illness unable give inform consent follow accord study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Corneal disorder</keyword>
	<keyword>Chemical injury</keyword>
	<keyword>Pterygium</keyword>
	<keyword>Refractive error</keyword>
	<keyword>Myopia</keyword>
	<keyword>Hyperopia</keyword>
	<keyword>Cornea</keyword>
	<keyword>Monocular</keyword>
	<keyword>Transparent</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Visual function</keyword>
</DOC>